Menu
Back to Journals » Biologics: Targets and Therapy » Volume 4
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (491)
- Volume 17, 2023 (12)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 4, 2010
Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?
Jürgen Frevert, Dirk Dressler
Biologics: Targets and Therapy 2010, 4:325-332
Published Date: 9 December 2010
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
Tariq I Mughal, Andrew Schrieber
Biologics: Targets and Therapy 2010, 4:315-323
Published Date: 2 December 2010
Gaucher disease: clinical profile and therapeutic developments
Timothy M Cox
Biologics: Targets and Therapy 2010, 4:299-313
Published Date: 6 December 2010
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
William Boland, Gwyn Bebb
Biologics: Targets and Therapy 2010, 4:289-298
Published Date: 9 November 2010
Proteasome inhibition and its therapeutic potential in multiple myeloma
Ajai Chari, Amitabha Mazumder, Sundar Jagannath
Biologics: Targets and Therapy 2010, 4:273-287
Published Date: 28 September 2010
New and emerging treatment approaches to lupus
Marion Haubitz
Biologics: Targets and Therapy 2010, 4:263-271
Published Date: 6 September 2010
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
Darja Kanduc
Biologics: Targets and Therapy 2010, 4:245-261
Published Date: 9 September 2010
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Jaclyn Flanigan, Hari Deshpande, Scott Gettinger
Biologics: Targets and Therapy 2010, 4:237-243
Published Date: 26 August 2010
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
Cary O Harding
Biologics: Targets and Therapy 2010, 4:231-236
Published Date: 6 August 2010
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
Aruna Chandran, Sean Fitzwater, Anjie Zhen, et al
Biologics: Targets and Therapy 2010, 4:213-229
Published Date: 30 July 2010
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent
Peter Reimer, Rolf Vosshenrich
Biologics: Targets and Therapy 2010, 4:199-212
Published Date: 4 August 2010
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Peter E Clark
Biologics: Targets and Therapy 2010, 4:187-197
Published Date: 28 June 2010
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Biologics: Targets and Therapy 2010, 4:173-185
Published Date: 28 June 2010
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies
Yuan Li, Janine A Burns, Carol A Cheney, et al
Biologics: Targets and Therapy 2010, 4:163-171
Published Date: 15 June 2010
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Josh Neman, Rahul Jandial
Biologics: Targets and Therapy 2010, 4:157-162
Published Date: 22 June 2010
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
J Paul Frindik, Stephen F Kemp
Biologics: Targets and Therapy 2010, 4:147-155
Published Date: 9 June 2010
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
Andreas Rank, Oliver Weigert, Helmut Ostermann
Biologics: Targets and Therapy 2010, 4:139-145
Published Date: 24 May 2010
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Ori Toker, Philip J Hashkes
Biologics: Targets and Therapy 2010, 4:131-138
Published Date: 17 May 2010
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Santo Raffaele Mercuri, Luigi Naldi
Biologics: Targets and Therapy 2010, 4:119-129
Published Date: 10 May 2010
Use of clofarabine for acute childhood leukemia
A Pession, R Masetti, K Kleinschmidt, et al
Biologics: Targets and Therapy 2010, 4:111-118
Published Date: 24 June 2010
Palliative treatment of malignant ascites: profile of catumaxomab
Lila Ammouri, Eric E Prommer
Biologics: Targets and Therapy 2010, 4:103-110
Published Date: 14 May 2010
Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
Chris Coppin
Biologics: Targets and Therapy 2010, 4:91-101
Published Date: 30 April 2010
Management of patients with advanced non-small cell lung cancer: role of gefitinib
Vamsidhar Velcheti, Daniel Morgensztern, Ramaswamy Govindan
Biologics: Targets and Therapy 2010, 4:83-90
Published Date: 19 April 2010
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Rosalia Ricco, Darja Kanduc
Biologics: Targets and Therapy 2010, 4:75-81
Published Date: 1 April 2010
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Brent Sorenson, Kaysie Banton, Lance Augustin, et al
Biologics: Targets and Therapy 2010, 4:61-73
Published Date: 16 March 2010
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency
Sabine Kroiss, Manuela Albisetti
Biologics: Targets and Therapy 2010, 4:51-60
Published Date: 9 March 2010
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Mohamed Mahdi-Rogers, Yusuf A Rajabally
Biologics: Targets and Therapy 2010, 4:45-49
Published Date: 9 March 2010
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis
Stephen P Myers, Joan O’Connor, J Helen Fitton, et al.
Biologics: Targets and Therapy 2010, 4:33-44
Published Date: 12 February 2010
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Richard Quek, Suzanne George
Biologics: Targets and Therapy 2010, 4:19-31
Published Date: 3 February 2010
Recombinant follitropin alfa/lutropin alfa in fertility treatment
Ahmed Gibreel, Siladitya Bhattacharya
Biologics: Targets and Therapy 2010, 4:5-17
Published Date: 22 December 2009
Safety of etanercept in elderly subjects with rheumatoid arthritis
Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al
Biologics: Targets and Therapy 2010, 4:1-4
Published Date: 22 December 2009